Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Total Current Liabilities Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Total Current Liabilities
kr4.4B
CAGR 3-Years
48%
CAGR 5-Years
53%
CAGR 10-Years
19%
Zealand Pharma A/S
CSE:ZEAL
Total Current Liabilities
kr257.2m
CAGR 3-Years
-12%
CAGR 5-Years
0%
CAGR 10-Years
23%
Ascendis Pharma A/S
NASDAQ:ASND
Total Current Liabilities
€851.4m
CAGR 3-Years
130%
CAGR 5-Years
70%
CAGR 10-Years
49%
B
Bavarian Nordic A/S
CSE:BAVA
Total Current Liabilities
kr3.6B
CAGR 3-Years
26%
CAGR 5-Years
73%
CAGR 10-Years
31%
F
Fluoguide AS
STO:FLUO
Total Current Liabilities
kr16.3m
CAGR 3-Years
10%
CAGR 5-Years
199%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Total Current Liabilities
kr23.2m
CAGR 3-Years
-2%
CAGR 5-Years
12%
CAGR 10-Years
9%

See Also

What is Genmab A/S's Total Current Liabilities?
Total Current Liabilities
4.4B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Total Current Liabilities amounts to 4.4B DKK.

What is Genmab A/S's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
19%

Over the last year, the Total Current Liabilities growth was 119%. The average annual Total Current Liabilities growth rates for Genmab A/S have been 48% over the past three years , 53% over the past five years , and 19% over the past ten years .

Back to Top